No results could be found for this keywords.
No results could be found for this keywords.
All ScienceStage.com Results for
j.h.-engdahl
Pubmed Results for
j.h.-engdahl
- Executive summary: heart disease and stroke statistics--2013 ...
1. Circulation. 2013 Jan 1;127(1):143-52. doi: 10.1161/CIR.0b013e318282ab8f. Executive summary: heart disease and stroke statistics--2013 update: a report from the ... - N-acetylcysteine augmentation in serotonin reuptake inhibitor ...
1. Psychopharmacology (Berl). 2006 Jan;184(2):254-6. Epub 2005 Dec 22. N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive ... - Physical activity, including walking, and cognitive function in ...
1. JAMA. 2004 Sep 22;292(12):1454-61. Physical activity, including walking, and cognitive function in older women. Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH ... - Can lifestyle changes reverse coronary heart disease? The ...
1. Lancet. 1990 Jul 21;336(8708):129-33. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Ornish D, Brown SE, Scherwitz LW, Billings ... - Heart disease and stroke statistics--2013 update: a report from ...
1. Circulation. 2013 Jan 1;127(1):e6-e245. doi: 10.1161/CIR.0b013e31828124ad. Epub 2012 Dec 12. Heart disease and stroke statistics--2013 update: a report from the ... - Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
1. N Engl J Med. 2010 Jul 15;363(3):221-32. doi: 10.1056/NEJMoa0909905. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. Stone JH, Merkel PA, Spiera ... - The effects of the cardiac myosin activator, omecamtiv mecarbil ...
1. Lancet. 2011 Aug 20;378(9792):676-83. doi: 10.1016/S0140-6736(11)61126-4. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in ... - Consensus statement of the European Group on Graves' orbitopathy ...
1. Eur J Endocrinol. 2008 Mar;158(3):273-85. doi: 10.1530/EJE-07-0666. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. - Correction of the F508del-CFTR protein processing defect in vitro ...
1. Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18843-8. doi: 10.1073/pnas.1105787108. Epub 2011 Oct 5. Correction of the F508del-CFTR protein processing defect in ... - Vitamin D deficiency an important, common, and easily treatable ...
1. J Am Coll Cardiol. 2008 Dec 9;52(24):1949-56. doi: 10.1016/j.jacc.2008.08.050. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk ...